VVOS

Vivos Therapeutics

Healthcare Medical Devices NASDAQ

About the company

The Vivos System developed by Vivos Therapeutics Inc. is a groundbreaking approach in the medical field that offers a non-surgical, non-invasive, non-pharmaceutical, and cost-effective solution for patients suffering from sleep-disordered breathing (SDB), specifically targeting mild-to-moderate obstructive sleep apnea (OSA). This innovative technology aims to provide individuals with a more comfortable and convenient treatment alternative to the traditional methods available. Obstructive sleep apnea is a prevalent condition characterized by the partial or complete blockage of the airways during sleep, leading to repetitive pauses in breathing and disrupted sleep patterns. It affects millions of people worldwide and is associated with various health risks, including increased blood pressure, cardiovascular problems, and daytime fatigue. Conventional treatments for OSA often involve invasive procedures such as surgery or the use of continuous positive airway pressure (CPAP) machines, which can be uncomfortable and inconvenient for patients. The Vivos System tackles these challenges by employing a personalized and comprehensive approach. It utilizes customized oral appliances that are specifically designed to improve airflow and keep the airways open during sleep. These appliances are individually tailored to each patient's unique anatomical specifications, ensuring optimal fit and effectiveness. The system also includes a set of protocols and techniques that are implemented by trained healthcare professionals to maximize the treatment's efficacy. The Vivos System addresses the underlying causes of sleep-disordered breathing, including anatomical deficiencies such as narrow airways, malocclusion, and a weak or recessed jaw position. By correcting these issues, the system promotes improved breathing patterns, reduces apneic events, and enhances sleep quality. This comprehensive approach not only alleviates the symptoms associated with OSA but also improves overall health and quality of life. One of the distinct advantages of the Vivos System is its non-surgical nature. Unlike traditional surgical procedures for OSA, which can be invasive, risky, and require lengthy recovery periods, the Vivos System offers a safe and minimally invasive alternative. The oral appliances are comfortable and convenient to wear, allowing patients to maintain their regular sleep routines without disruption. Furthermore, the system offers individualized treatment plans tailored to each patient's specific needs, ensuring maximum effectiveness. In addition to its non-surgical approach, the Vivos System distinguishes itself by being non-pharmaceutical. This means that patients do not rely on medication to manage their sleep-disordered breathing. Instead, the system addresses the root cause of the condition, reducing the need for pharmaceutical interventions and potential side effects. This can be particularly beneficial for those who prefer drug-free treatment options or are seeking alternatives to long-term medication use. Moreover, the Vivos System offers a cost-effective solution for patients with mild-to-moderate OSA. The customized oral appliances and protocols are designed to provide significant benefits at a lower cost compared to surgical interventions or the long-term use of CPAP machines. This affordability opens up treatment options for a broader range of individuals, allowing more patients to access the benefits of this innovative technology. In summary, Vivos Therapeutics Inc. has developed a pioneering technology in the form of the Vivos System, which offers a non-surgical, non-invasive, non-pharmaceutical, and cost-effective solution for patients suffering from sleep-disordered breathing, specifically mild-to-moderate obstructive sleep apnea. By providing customized oral appliances and comprehensive protocols, the Vivos System addresses the underlying causes of OSA, promotes better breathing patterns and enhanced sleep quality, and improves overall health and well-being. With its comfort, convenience, individualized treatment plans, and affordability, the Vivos System represents a significant advancement in the field of sleep medicine and offers hope for millions of individuals seeking effective and accessible treatments for sleep-disordered breathing conditions.

Website: https://www.vivos.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1345 peers in sector

Metric VVOS Sector median Vs. industry
P/E - 20.13
EPS -2.14 USD -1.14 USD ↓ Below average
Dividend yield 0.00% 0.00%
Profit margin -1.28% 0.00% ↓ Below average
ROE -16.00% -58.89% ↓ Below average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Vivos Therapeutics?
The Vivos System developed by Vivos Therapeutics Inc. is a groundbreaking approach in the medical field that offers a non-surgical, non-invasive, non-pharmaceutical, and cost-effective solution for patients suffering from sleep-disordered breathing (SDB), specifically targeting mild-to-moderate obstructive sleep apnea (OSA). This innovative technology aims to provide individuals with a more comfortable and convenient treatment alternative to the traditional methods available. Obstructive sleep apnea is a prevalent condition characterized by the partial or complete blockage of the airways during sleep, leading to repetitive pauses in breathing and disrupted sleep patterns. It affects millions of people worldwide and is associated with various health risks, including increased blood pressure, cardiovascular problems, and daytime fatigue. Conventional treatments for OSA often involve invasive procedures such as surgery or the use of continuous positive airway pressure (CPAP) machines, which can be uncomfortable and inconvenient for patients. The Vivos System tackles these challenges by employing a personalized and comprehensive approach. It utilizes customized oral appliances that are specifically designed to improve airflow and keep the airways open during sleep. These appliances are individually tailored to each patient's unique anatomical specifications, ensuring optimal fit and effectiveness. The system also includes a set of protocols and techniques that are implemented by trained healthcare professionals to maximize the treatment's efficacy. The Vivos System addresses the underlying causes of sleep-disordered breathing, including anatomical deficiencies such as narrow airways, malocclusion, and a weak or recessed jaw position. By correcting these issues, the system promotes improved breathing patterns, reduces apneic events, and enhances sleep quality. This comprehensive approach not only alleviates the symptoms associated with OSA but also improves overall health and quality of life. One of the distinct advantages of the Vivos System is its non-surgical nature. Unlike traditional surgical procedures for OSA, which can be invasive, risky, and require lengthy recovery periods, the Vivos System offers a safe and minimally invasive alternative. The oral appliances are comfortable and convenient to wear, allowing patients to maintain their regular sleep routines without disruption. Furthermore, the system offers individualized treatment plans tailored to each patient's specific needs, ensuring maximum effectiveness. In addition to its non-surgical approach, the Vivos System distinguishes itself by being non-pharmaceutical. This means that patients do not rely on medication to manage their sleep-disordered breathing. Instead, the system addresses the root cause of the condition, reducing the need for pharmaceutical interventions and potential side effects. This can be particularly beneficial for those who prefer drug-free treatment options or are seeking alternatives to long-term medication use. Moreover, the Vivos System offers a cost-effective solution for patients with mild-to-moderate OSA. The customized oral appliances and protocols are designed to provide significant benefits at a lower cost compared to surgical interventions or the long-term use of CPAP machines. This affordability opens up treatment options for a broader range of individuals, allowing more patients to access the benefits of this innovative technology. In summary, Vivos Therapeutics Inc. has developed a pioneering technology in the form of the Vivos System, which offers a non-surgical, non-invasive, non-pharmaceutical, and cost-effective solution for patients suffering from sleep-disordered breathing, specifically mild-to-moderate obstructive sleep apnea. By providing customized oral appliances and comprehensive protocols, the Vivos System addresses the underlying causes of OSA, promotes better breathing patterns and enhanced sleep quality, and improves overall health and well-being. With its comfort, convenience, individualized treatment plans, and affordability, the Vivos System represents a significant advancement in the field of sleep medicine and offers hope for millions of individuals seeking effective and accessible treatments for sleep-disordered breathing conditions.
How big is Vivos Therapeutics?
The market capitalization of Vivos Therapeutics — the combined value of all its shares — is 9.5 M USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Vivos Therapeutics pay dividends?
The dividend yield of Vivos Therapeutics is 0.00% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Vivos Therapeutics belong to?
Vivos Therapeutics operates in the Healthcare sector, industry: Medical Devices.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120